Morgan Stanley’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.7M | Buy |
|
|||||
|
2025
Q1 | $83M | Buy |
|
|||||
|
2024
Q4 | $73.9M | Buy |
|
|||||
|
2024
Q3 | $83.6M | Buy |
|
|||||
|
2024
Q2 | $64.8M | Buy |
|
|||||
|
2024
Q1 | $22.8M | Sell |
|
|||||
|
2023
Q4 | $34.9M | Buy |
|
|||||
|
2023
Q3 | $10.7M | Buy |
|
|||||
|
2023
Q2 | $11.7M | Buy |
|
|||||
|
2023
Q1 | $14.8M | Buy |
|
|||||
|
2022
Q4 | $564K | Buy |
|
|||||
|
2022
Q3 | $405K | Sell |
|
|||||
|
2022
Q2 | $595K | Buy |
|
|||||
|
2022
Q1 | $587K | Sell |
|
|||||
|
2021
Q4 | $930K | Buy |
|
|||||
|
2021
Q3 | $950K | Sell |
|
|||||
|
2021
Q2 | $884K | Sell |
|
|||||
|
2021
Q1 | $3.76M | Sell |
|
|||||
|
2020
Q4 | $5.05M | Sell |
|
|||||
|
2020
Q3 | $9.11M | Sell |
|
|||||
|
2020
Q2 | $6.1M | Buy |
|
|||||
|
2020
Q1 | $2.07M | Buy |
|
|||||
|
2019
Q4 | $5.2M | Buy |
|
|||||
|
2019
Q3 | $2.5M | Buy |
|
|||||
|
2019
Q2 | $3.35M | Buy |
|
|||||
|
2019
Q1 | $3.46M | Sell |
|
|||||
|
2018
Q4 | $4.16M | Buy |
|
|||||
|
2018
Q3 | $9.69M | Buy |
|
|||||
|
2018
Q2 | $5.37M | Buy |
|
|||||
|
2018
Q1 | $2.57M | Sell |
|
|||||
|
2017
Q4 | $3.17M | Buy |
|
|||||
|
2017
Q3 | $2.61M | Buy |
|
|||||
|
2017
Q2 | $1.18M | Buy |
|
|||||
|
2017
Q1 | $951K | Buy |
|
|||||
|
2016
Q4 | $681K | Buy |
|
|||||
|
2016
Q3 | $464K | Buy |
|
|||||
|
2016
Q2 | $347K | Buy |
|
|||||
|
2016
Q1 | $167K | Buy |
|
|||||
|
2015
Q4 | $98K | Sell |
|
|||||
|
2015
Q3 | $774K | Buy |
|
|||||
|
2015
Q2 | $1.18M | Buy |
|
|||||
|
2015
Q1 | $665K | Buy |
|
|||||
|
2014
Q4 | $444K | Sell |
|
|||||
|
2014
Q3 | $9.36M | Buy |
|
|||||
|
2014
Q2 | $331K | Sell |
|
|||||
|
2014
Q1 | $5.37M | Buy |
|
|||||
|
2013
Q4 | $12K | Buy |
|